Hong Kong
· Delayed Price · Currency is HKD Venus Medtech (Hangzhou) Company Description
Venus Medtech (Hangzhou) Inc., together with its subsidiaries, engages in the research, development, clinical development, manufacturing, and sale of bioprosthetic heart valves in Mainland China and internationally.
The company’s offers transcatheter aortic heart valve replacement products, such as VenusA-Valve, VenusA-Plus, and VenusA-Pro; and VenusP-Valve is a transcatheter pulmonary valve system to treat the patients suffering with moderate to severe pulmonary regurgitation with or without right ventricular outflow tract stenosis.
It also develops Venus-Vitae, a balloon-expandable dry-tissue product; Venus-PowerX, a self-expanding dry-tissue product; Cardiovalve, a transcatheter valve replacement system for the treatment of patients with mitral regurgitation and in pivotal clinical trial for the treatment of patients with tricuspid regurgitation; Liwen RF, a radiofrequency ablation system for the treatment of hypertrophic cardiomyopathy; and renal artery denervation ablation system for the treatment of hypertension.
In addition, the company offers procedural accessories comprising catheter sheath product and balloon catheter.
Venus Medtech (Hangzhou) Inc. was incorporated in 2009 and is headquartered in Hangzhou, the People’s Republic of China.
| Country | China |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 691 |
| CEO | Hou-Sen Lim |
Contact Details
Address: No. 88, Jiangling Road Hangzhou, 310051 China | |
| Phone | 86 571 8777 2180 |
| Website | venusmedtech.com |
Stock Details
| Ticker Symbol | 2500 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003PJ8 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Hou-Sen Lim MEng. | GM, Chief Operating Officer and Chief Technology Officer and Executive Director |
| Liu Meirong | Vice President and Executive Director |
| Liqiao Ma | Vice President of clinical medicine and Executive Director |
| Zhu Bing | Chief Financial Officer |
| Joyce Heo | Director of Sales |
| Christopher Lee Richardson | Head of U.S. Operations |
| Amir Gross | Head of Venus Global Heart Valve Innovation Center |
| Shakeel Osman | Head of International Congenital Heart Disease Business |
| Wai Chiu Wong FCS | Company Secretary |